The FDA has approved a screening test for the breast cancer gene that women will soon be able to order without consulting a doctor. But some geneticists fear the new test will give people a false sense of security. We’ll discuss screening methodology and a University of California study that compares the accuracy of genetic tests to mammograms for predicting breast cancer risk.
Guests:
Dr. Laura Esserman, professor of surgery and radiology and director, Carol Franc Buck Breast Care Center at UCSF; principal investigator of the Wisdom Study
Carrie Feibel, health editor, KQED